This article was originally published in The Gray Sheet
Plans to repurchase up to 200,000 shares of common stock "in the open market or through privately negotiated transactions from time to time," according to the firm. The Whippany, New Jersey firm also reports that earnings are expected to be flat for the year and revenue growth less than previously anticipated due to lower than expected utilization levels at some of its sterilization facilities....
You may also be interested in...
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.